Jason Potter
Overview
Explore the profile of Jason Potter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang P, Ding B, Reyes C, Papp D, Potter J
Biotechniques
. 2023 May;
74(5):211-224.
PMID: 37161298
Designed donor DNA delivery through viral or nonviral systems to target loci in the host genome is a critical step for gene therapy. Adeno-associated virus and lentivirus are leading vehicles...
2.
Senthilvelan A, Vonderfecht T, Shanmugasundaram M, Potter J, Kore A
Bioorg Med Chem
. 2022 Dec;
77:117128.
PMID: 36516685
The first example of the synthesis of a new trinucleotide cap analog containing propargyl group such as mG(5')PPP(5')ApG is reported. The effect of the propargyl group in trinucleotide analog with...
3.
Senthilvelan A, Vonderfecht T, Shanmugasundaram M, Pal I, Potter J, Kore A
Org Lett
. 2021 May;
23(11):4133-4136.
PMID: 34008991
The synthesis of a new trinucleotide cap analogue containing a locked nucleic acid (LNA) moiety such as mG(5')ppp(5')ApG and its molecular biology applications are described. The most appealing feature is...
4.
Sun T, Kwok W, Chua K, Lo T, Potter J, Yew W, et al.
ACS Synth Biol
. 2020 May;
9(7):1864-1872.
PMID: 32470293
Chinese hamster ovary (CHO) cells are the superior host cell culture models used for the bioproduction of therapeutic proteins. One of the prerequisites for bioproduction using CHO cell lines is...
5.
Charlesworth C, Camarena J, Cromer M, Vaidyanathan S, Bak R, Carte J, et al.
Mol Ther Nucleic Acids
. 2018 Sep;
12:89-104.
PMID: 30195800
Engineered nuclease-mediated gene targeting through homologous recombination (HR) in hematopoietic stem and progenitor cells (HSPCs) has the potential to treat a variety of genetic hematologic and immunologic disorders. Here, we...
6.
Tang P, Ding B, Peng L, Mozhayskiy V, Potter J, Chesnut J
Biotechniques
. 2018 Aug;
65(5):259-267.
PMID: 30114933
GUIDE-seq was developed to detect CRISPR/Cas9 off-target. However, as originally reported, it was associated with a high level of nonspecific amplification. In an attempt to improve it, we developed target-enriched...
7.
Ichikawa H, Cooper J, Lo L, Potter J, Terns R, Terns M
PLoS One
. 2017 Apr;
12(4):e0176221.
PMID: 28441427
The CRISPR-Cas systems provide invader defense in a wide variety of prokaryotes, as well as technologies for many powerful applications. The Type III-A or Csm CRISPR-Cas system is one of...
8.
Jestico B, Nelson T, Potter J, Winters M
Accid Anal Prev
. 2017 Apr;
103:65-71.
PMID: 28384490
Real and perceived concerns about cycling safety are a barrier to increased ridership in many cities. Many people prefer to bike on facilities separated from motor vehicles, such as multiuse...
9.
Liang X, Potter J, Kumar S, Ravinder N, Chesnut J
J Biotechnol
. 2016 Nov;
241:136-146.
PMID: 27845164
While CRISPR-based gene knock out in mammalian cells has proven to be very efficient, precise insertion of genetic elements via the cellular homology directed repair (HDR) pathway remains a rate-limiting...
10.
Yu X, Liang X, Xie H, Kumar S, Ravinder N, Potter J, et al.
Biotechnol Lett
. 2016 Feb;
38(6):919-29.
PMID: 26892225
Objectives: To identify the best lipid nanoparticles for delivery of purified Cas9 protein and gRNA complexes (Cas9 RNPs) into mammalian cells and to establish the optimal conditions for transfection. Results:...